Discovery of a novel class of Nrf2 activators as a neuroprotective agent for treatment of Parkinson’s disease

Item Number: 626
Industry: Therapeutic
Category: Neuroscience / Neurology
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea
Business Opportunity: Out-Licensing


The present invention relates to development of novel vinylsulfone compounds as Nrf2 activator for treatment of Parkinson’s disease (PD).

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it